Titre:
  • Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
Auteur:Struyf, Sofie; Salogni, Laura; Burdick, Marie D; Vandercappellen, Jo; Gouwy, Mieke; Noppen, Samuel; Proost, Paul; Opdenakker, Ghislain; Parmentier, Marc; Gerard, Craig; Sozzani, Silvano; Strieter, Robert M; Van Damme, Jo
Informations sur la publication:Blood, 117, 2, page (480-488)
Statut de publication:Publié, 2011-01
Sujet CREF:Pharmacologie moléculaire et cellulaire
Immunologie
MeSH keywords:Angiogenesis Inhibitors -- metabolism -- pharmacology
Animals
Antineoplastic Agents -- metabolism -- pharmacology
Chemotactic Factors -- metabolism -- pharmacology
Chemotaxis, Leukocyte -- drug effects -- physiology
Dendritic Cells -- metabolism
Endothelial Cells -- drug effects -- metabolism
Humans
Mice
Mice, Inbred C57BL
Neoplasms, Experimental -- drug therapy -- metabolism
Platelet Factor 4 -- metabolism -- pharmacology
Rats
Receptors, CXCR3 -- metabolism
Transfection
Xenograft Model Antitumor Assays
Note générale:Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:doi/10.1182/blood-2009-11-253591
info:pii/blood-2009-11-253591
info:scp/78751562091
info:pmid/20980681
PMC3031477